Low-dose ketamine effective in reducing the incidence of shivering following spinal anesthesia

Written By :  Dr. Shravani Dali
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2022-12-07 14:00 GMT   |   Update On 2022-12-08 09:35 GMT

Low-dose ketamine was effective in reducing the incidence of shivering following spinal anaesthesia compared to tramadol suggests a recent study published in the BMC AnesthesiologyPost-spinal shivering is a common complication after spinal anesthesia with a high incidence among orthopedic patients. Untreated shivering may predispose to exacerbation of wound pain, increased metabolic...

Login or Register to read the full article

Low-dose ketamine was effective in reducing the incidence of shivering following spinal anaesthesia compared to tramadol suggests a recent study published in the BMC Anesthesiology

Post-spinal shivering is a common complication after spinal anesthesia with a high incidence among orthopedic patients. Untreated shivering may predispose to exacerbation of wound pain, increased metabolic demand, oxygen consumption, and hemostatic dysfunction. Various studies have been done on the effectiveness of preventing post-spinal shivering using ketamine and other drugs. However, little information on better prophylactic agents in terms of effectiveness and availability. Therefore, this study was intended to compare 0.25 mg/kg of Ketamine (K) versus 0.5 mg/kg of Tramadol (T) for the prevention of post-spinal shivering.

A prospective cohort study design was employed on 516 patients undergoing orthopedic surgery under spinal anesthesia, and they were selected by a consecutive sampling technique. Patients were divided into two groups based on the anesthetist in charge. Patients who received an intravenous prophylactic dose of Ketamine before spinal anesthesia are called Ketamine groups and patients who received Tramadol are called Tramadol groups (control). The severity and incidence of shivering, blood pressure, heart rate, and axillary body temperature were measured and recorded for one hour at 10-min intervals during the intraoperative period. Descriptive statistics, chi-square, independent t-test, and multivariable logistic regression were used. Significance was declared at a p-value lower than 0.05.
Results:
  • The overall incidence of post-spinal shivering was 187 (36.2%), of which it was 74 (28.7%) on ketamine and 113 (43.8%) on tramadol with a p-value of 0.001.

  • The incidence of nausea and vomiting was 157 (60.9%) on tramadol and 8 (3.1%) on ketamine, with a p-value of 0.001.

  • Patients aged 18-35 years, 36-55 years, and those patients with a prolonged duration of surgery were more likely to experience post-spinal shivering.

  • And Low-dose ketamine has a protective effect against developing post-spinal shivering with an AOR of 0.427

Low-dose ketamine is more effective in reducing the incidence and severity of shivering after spinal anesthesia. Therefore, we recommend using low-dose ketamine to be effective as a prophylactic for post-spinal shivering in those patients undergoing orthopedic surgery under spinal anesthesia.

Reference:

Gemechu AD, Gebremedhin TD, Andebiku AA, Solomon F, Sorsa A. The effect of ketamine versus tramadol on prophylactic post-spinal shivering in those patients undergoing orthopedic surgery: a prospective cohort study design, 2020. BMC Anesthesiol. 2022 Nov 24;22(1):361. doi: 10.1186/s12871-022-01906-z. PMID: 36424561.

Keywords:

Low-dose ketamine, effective,reducing the incidence of shivering following spinal anesthesia compared to tramadol, Gemechu AD, Gebremedhin TD, Andebiku AA, Solomon F, Sorsa A, BMC Anesthesiology, Ketamine; Orthopedic surgery; Post-spinal shivering; Spinal anaesthesia; Tramadol.

Tags:    
Article Source : BMC Anesthesiology

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News